Employees: NN (None)Legal category: 5485Size: PMECreation date: 2022-05-01 (3 years)Status: ActiveBusiness sector: Gestion de fondsLocation: NARBONNE (11100), Aude
Les données financières de cette entreprise sont partiellement disponibles (liasse simplifiée ou données confidentielles). Certaines sections ne sont pas affichées.
PHARMALAUPILAU : revenue, balance sheet and financial ratios
PHARMALAUPILAU is a French company
founded 3 years ago,
specialized in the sector Gestion de fonds.
Based in NARBONNE (11100),
this company of category PME
shows in 2023 a net income negative of -9 k€.
Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.
Financial history - PHARMALAUPILAU (SIREN 912387321)
Indicator
2023
Revenue
N/C
Net income
-8 926 €
EBITDA
-6 828 €
Net margin
N/C
Revenue and income statement
In 2023, PHARMALAUPILAU records a net loss of 9 k€. This deficit will reduce equity on the balance sheet.
EBITDA (2023)
?
Gross Operating Surplus (EBITDA)
Definition
Resources generated by current operations, before depreciation and financial expenses.
Formula
Value added - Personnel expenses - Taxes
Interpretation
Positive = profitable activity
-6 828 €
EBIT (2023)
?
EBIT (Operating Income)
Definition
Operating income, including depreciation and provisions.
Formula
EBITDA - Depreciation and provisions + Reversals
-6 828 €
Net income (2023)
?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax
-8 926 €
Loading income statement...
Income statement
Item
Amount
% Revenue
Change
The detailed income statement is not available for this company (simplified accounts or confidential data).
Chart evolution
Show :
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Assets
Loading data...
Item
Gross
Deprec.
Net
%
Change
Assets balance sheet data not available for this company
Liabilities
Loading data...
Item
Year
%
Change
Liabilities balance sheet data not available for this company
Solvency and debt ratios
The debt ratio (= Financial debt / Equity x 100) stands at 437%. Critical situation: debt significantly exceeds equity, severely limiting borrowing capacity and exposing the company to default risk. Financial autonomy (= Equity / Total assets x 100) reaches 19%. Low autonomy: the company heavily depends on external financing (banks, suppliers).
Debt ratio (2023)
?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low 50-100% : Moderate > 100% : High
436.948%
Financial autonomy (2023)
?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy 20-30% : Average < 20% : Low
18.624%
Repayment capacity (2023)
?
Repayment capacity
Definition
Number of years needed to repay debts with cash flow.
Formula
Financial debt / Cash flow
Interpretation
< 3 years : Excellent 3-5 years : Fair > 5 years : Warning
-40.016
Solvency indicators evolution PHARMALAUPILAU
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Indicator
2023
Debt ratio
436.948
Financial autonomy
18.624
Repayment capacity
-40.016
Cash flow / Revenue
None%
Sector positioning
Debt ratio
436.952023
2023
Q1: 0.0
Med: 10.73
Q3: 105.57
Average
In 2023, the debt ratio of PHARMALAUPILAU (436.95) ranks above the median of the sector. This ratio measures the weight of debt relative to equity. A reduction effort could improve financial strength.
Financial autonomy
18.62%2023
2023
Q1: 7.74%
Med: 49.44%
Q3: 87.29%
Average
In 2023, the financial autonomy of PHARMALAUPILAU (18.6%) ranks below the median of the sector. This ratio represents the share of equity in total financing. An improvement would strengthen the competitive position.
Repayment capacity
-40.02 years2023
2023
Q1: -0.04 years
Med: 0.0 years
Q3: 3.17 years
Excellent
In 2023, the repayment capacity of PHARMALAUPILAU (-40.02) ranks in the bottom 25% of the sector, which is positive. This ratio indicates the number of years needed to repay debt with cash flow. A short capacity reflects controlled debt and good cash generation.
Liquidity ratios
Interest coverage (2023)
?
Interest coverage
Definition
Ability to cover interest charges with operating income.
Formula
EBIT / Interest expenses
Interpretation
> 3 : Comfortable 1.5-3 : Acceptable < 1.5 : Risk
-30.726
Liquidity indicators evolution PHARMALAUPILAU
Visualisation créée via abddaf.fr Sources : INPI & BCE - Retraitements : Ministère de l'économie
Indicator
2023
Liquidity ratio
None
Interest coverage
-30.726
Sector positioning
Interest coverage
-30.73x2023
2023
Q1: -59.6x
Med: 0.0x
Q3: 0.0x
Average
In 2023, the interest coverage of PHARMALAUPILAU (-30.7x) ranks below the median of the sector. This ratio indicates how many times operating income covers interest expenses. An improvement would strengthen the competitive position.
Positioning of PHARMALAUPILAU in its sector
Comparison with sector Gestion de fonds
Similar companies (Gestion de fonds)
Compare PHARMALAUPILAU with other companies in the same sector:
The revenue of PHARMALAUPILAU is not publicly disclosed (confidential accounts filed with INPI).
Is PHARMALAUPILAU profitable?
PHARMALAUPILAU recorded a net loss in 2023.
Where is the headquarters of PHARMALAUPILAU ?
The headquarters of PHARMALAUPILAU is located in NARBONNE (11100), in the department Aude.
Where to find the tax return of PHARMALAUPILAU ?
The tax return of PHARMALAUPILAU is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).
In which sector does PHARMALAUPILAU operate?
PHARMALAUPILAU operates in the sector Gestion de fonds (NAF code 66.30Z). See the 'Sector positioning' section above to compare the company with its competitors.
Item evolution
Rotate your phone to landscape mode to view the chart